Sign in
4

Changes in Ownership

IRulya Therapeutics Inc. Filed Acc 0001415889-25-003615

Options or other derivatives

  • PRESIDENT acquired 300,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Derivatives
Ryan Charles S. PRESIDENT 2025-01-28 Grant or award · Employee Stock Option (right to buy) +300,000 300,000 D
Loading xslF345X05/form4-02112025_100214.xml…